Get started
Author

Shauna H. Hillman

Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer
2003 · Alex A. Adjei, Ann Mauer, et al. · Journal of Clinical Oncology · 219
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer
2006 · Steven E. Schild, William L. McGinnis, et al. · International Journal of Radiation Oncology*Biology*Physics · 135
Storytelling
2000 · Jane Harper Chelf, Amy M. B. Deshler, et al. · Cancer Nursing · 54
A Phase II Study of the Dolastatin 15 Analogue LU 103793 in the Treatment of Advanced Non–Small-Cell Lung Cancer
2003 · Randolph S. Marks, David L. Graham, et al. · American Journal of Clinical Oncology · 39
Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age)
2003 · Aminah Jatoi, Philip J. Stella, et al. · American Journal of Clinical Oncology · 29
Learning and Support Preferences of Adult Patients With Cancer at a Comprehensive Cancer Center
2002 · Jane Harper Chelf, Amy M.B. Deshler, et al. · Oncology nursing forum · 22
Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study
2009 · Ping Yang, Sumithra J. Mandrekar, et al. · Journal of Thoracic Oncology · 20
Results of a Phase I Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer
2005 · S.E. Schild, W.L. McGinnis, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
A Phase II Trial of Edatrexate, Vinblastine, Adriamycin, Cisplastin, and Filgrastim (EVAC/G-CSF) in Patients With Non–Small-Cell Carcinoma of the Lungs
2001 · Gerardo Colon-Otero, Robert D. Niedringhaus, et al. · American Journal of Clinical Oncology · 16
Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer
2004 · Edith A Perez, Francois J Geoffroy, et al. · Lung Cancer · 12
O-68 Long term results of a phase III trial comparing once a day radiotherapy (qd RT) or twice a day radiotherapy (bid RT) in limited stage small cell lung cancer (LSCLC)
2003 · Steven E. Schild, Jeffery S. Brindle, et al. · Lung Cancer · 9
Radiofrequency Ablation of Stage 1A NSCLC in Medically Inoperable Patients: Results from ACOSOG Z4033 (Alliance), an NCI Funded Multicenter Trial
2013 · Damian Dupuy, Hiran Fernando, et al. · CHEST Journal · 7
Untitled
2003 · Randolph Marks, David Graham, et al. · American Journal of Clinical Oncology · 7
Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?
2006 · Aminah Jatoi, Shauna Hillman, et al. · PubMed · 5
O-73 High dose, twice-daily thoracic radiotherapy (TRT) with daily chemotherapy in limited stage small cell lung cancer
2003 · James A. Bonner, Shauna Hillman, et al. · Lung Cancer · 4
P1.16-47 Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
2018 · G. Oxnard, S. Mandrekar, et al. · Journal of Thoracic Oncology · 1
PDF
Docetaxel and irinotecan: An active non-platinum based regimen for the treatment of non-small cell lung cancer
2000 · A.A Adjei, S Hillman, et al. · Lung Cancer · 1
MA15.05 Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients in The U.S. ALCHEMIST Study (Alliance)
2021 · K. Kehl, D. Zahrieh, et al. · Journal of Thoracic Oncology
PDF
Adverse event (AE) attribution in symptom intervention and cancer prevention trials.
2016 · Jennifer Le-Rademacher, Shauna Hillman, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 600
H-index: 10
I10-index: 10
Year
Topic
Type